The translocator protein (TSPO): A novel target for cancer chemotherapy

被引：75
作者：
Austin, Christopher J. D. [1 ]
Kahlert, Jan [1 ]
Kassiou, Michael [1 ]
Rendina, Louis M. [1 ]
机构：
[1] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
来源：
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | 2013年 / 45卷 / 07期
关键词：
Translocator protein; TSPO; Cancer; Apoptosis; Cell homoeostasis; PERIPHERAL BENZODIAZEPINE-RECEPTOR; 18 KDA TSPO; MITOCHONDRIAL PERMEABILITY TRANSITION; DEPENDENT ANION CHANNELS; BINDING-SITES; COLONIC ADENOCARCINOMA; CHOLESTEROL TRANSPORT; DISEASE STATES; LIGANDS; TUMORS;
D O I：
10.1016/j.biocel.2013.03.004
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The translocator protein (TSPO) is an 18 kDa transmembrane protein primarily found in the outer mitochondrial membrane where it forms a key part of the mitochondrial permeability transition pore (MFTP). Omnipresent in almost all tissues, TSPO up-regulation has been connected to neuronal damage and inflammation, making the protein an important bio-imaging marker for disease progression. More recently, TSPO has attracted attention as a possible molecular target for tumour imaging and chemotherapy. In this review we summarize TSPO's molecular characteristics and highlight research progress in recent years in the field of TSPO-targeted cancer diagnostics and treatments. Crown Copyright (C) 2013 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：1212 / 1216
页数：5
相关论文
共 41 条
  • [21] DRAMATIC INCREASE IN PERIPHERAL BENZODIAZEPINE BINDING-SITES IN HUMAN COLONIC ADENOCARCINOMA AS COMPARED TO NORMAL COLON
    KATZ, Y
    EITAN, A
    AMIRI, Z
    GAVISH, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 148 (03) : 483 - 484
  • [22] INCREASED DENSITY OF PERIPHERAL BENZODIAZEPINE-BINDING SITES IN OVARIAN CARCINOMAS AS COMPARED WITH BENIGN OVARIAN-TUMORS AND NORMAL OVARIES
    KATZ, Y
    BENBARUCH, G
    KLOOG, Y
    MENCZER, J
    GAVISH, M
    [J]. CLINICAL SCIENCE, 1990, 78 (02) : 155 - 158
  • [23] KATZ Y, 1990, ONCOLOGY-BASEL, V47, P139
  • [24] The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore
    Kokoszka, JE
    Waymire, KG
    Levy, SE
    Sligh, JE
    Cal, JY
    Jones, DP
    MacGregor, GR
    Wallace, DC
    [J]. NATURE, 2004, 427 (6973) : 461 - 465
  • [25] Three-Dimensional Structure of TspO by Electron Cryomicroscopy of Helical Crystals
    Korkhov, Vladimir M.
    Sachse, Carsten
    Short, Judith M.
    Tate, Christopher G.
    [J]. STRUCTURE, 2010, 18 (06) : 677 - 687
  • [26] Voltage-dependent anion channel involved in the mitochondrial calcium cycle of cell lines carrying the mitochondrial DNA A4263G mutation
    Liu, Yuqi
    Gao, Lei
    Xue, Qiao
    Li, Zongbin
    Wang, Lin
    Chen, Rui
    Liu, Mohan
    Wen, Yi
    Guan, Minxin
    Li, Yang
    Wang, Shiwen
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 404 (01) : 364 - 369
  • [27] The development of PET radioligands for imaging the translocator protein (18 kDa): What have we learned?
    Luus, Christopher
    Hanani, Raphy
    Reynolds, Aaron
    Kassiou, Michael
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2010, 53 (7-8) : 501 - 510
  • [28] Translocator Protein (18 kDa) as a Target for Novel Anxiolytics with a Favourable Side-Effect Profile
    Nothdurfter, C.
    Rammes, G.
    Baghai, T. C.
    Schuele, C.
    Schumacher, M.
    Papadopoulos, V.
    Rupprecht, R.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2012, 24 (01) : 82 - 92
  • [29] PRESENCE OF PERIPHERAL-TYPE BENZODIAZEPINE BINDING-SITES ON HUMAN-ERYTHROCYTE MEMBRANES
    OLSON, JMM
    CILIAX, BJ
    MANCINI, WR
    YOUNG, AB
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 152 (1-2) : 47 - 53
  • [30] Translocator protein (18 kDa) ligand PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl- secretion in HT-29 human colon cancer cells
    Ostuni, Mariano A.
    Ducroc, Robert
    Peranzi, Gabriel
    Tonon, Marie-Christine
    Papadopoulos, Vassilios
    Lacapere, Jean-Jacques
    [J]. BIOLOGY OF THE CELL, 2007, 99 (11) : 639 - 647
12345